<DOC>
	<DOCNO>NCT00004740</DOCNO>
	<brief_summary>OBJECTIVES : I . Recruit 300 injection drug user positive tuberculin skin test candidate isoniazid chemoprophylaxis trial several intervention enhance adherence preventive therapy . II . Compare effectiveness self-administered isoniazid chemoprophylaxis supplement peer education support group versus directly observe preventive therapy deliver licensed nurse versus self-administered therapy standard clinic follow-up education . Outcome measure adherence prescribed dose medication proportion patient complete therapy . III . Compare impact monetary incentive therapy adherence random assignment immediate vs. defer financial incentive . IV . Assess attitude , knowledge , beliefs tuberculosis preventive therapy patient determine association factor demographic , social , clinical characteristic . V. Assess attitude beliefs tuberculosis susceptibility , seriousness , benefit preventive therapy , barrier therapy , self-efficacy predictor health-related behavior measure adherence therapy , determine impact assign intervention attitude belief .</brief_summary>
	<brief_title>Randomized Study Interventions Enhance Adherence Isoniazid Prevention Therapy Tuberculosis Injection Drug Users</brief_title>
	<detailed_description>PROTOCOL OUTLINE : This randomize study . Patients first group self-administer oral isoniazid follow standard clinic protocol 6 month . They receive individual counseling education peer educator entry week 2 , participate monthly support group cofacilitated peer counselor health educator , make monthly clinic visit . Patients second group receive oral isoniazid twice week . Therapy administer nurse , observe ingestion swallow . Nursing education support per standard clinic procedure provide monthly clinic visit . Patients third group self-administer oral isoniazid , without enhanced education peer support , follow standard clinic protocol 6 month . Nursing education support per standard clinic procedure provide monthly clinic visit . Within group , patient randomly assign immediate defer financial compensation schedule . Immediate compensation compliance medication clinical visit give monthly clinic visit , deferred compensation give study completion . It recommend HIV-seropositive patient receive 6 additional month standard isoniazid therapy .</detailed_description>
	<mesh_term>Tuberculosis</mesh_term>
	<mesh_term>Isoniazid</mesh_term>
	<criteria>PROTOCOL ENTRY CRITERIA : Population Characteristics Positive purify protein derivative ( PPD ) tuberculin skin test , induration follow : 10 mm great HIV seronegative 5 mm great HIV seropositive status unknown No active tuberculosis ( TB ) chest xray Candidate isoniazid prophylaxis Baltimore City Health Department Active treat injection drug user , i.e . : Injected illicit drug within last 3 month OR Previously inject drug drug treatment Injection use document : Subject self report Medical referral record drug treatment program Physical exam stigma injection drug use Prior/Concurrent Therapy No 6 month prior TB preventive therapy HIV Subject Characteristics Hepatic : ALT great 3 x ULN Renal : Not specify Other : No prior serious adverse reaction isoniazid No requirement HIV therapy Pneumocystis prophylaxis antiretrovirals</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 1998</verification_date>
	<keyword>cardiovascular respiratory disease</keyword>
	<keyword>rare disease</keyword>
	<keyword>tuberculosis</keyword>
</DOC>